戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  a previously undescribed dominant Mendelian platelet disorder.
2           Immune thrombocytopenia (ITP) is a platelet disorder.
3  manufacturing and for managing quantitative platelet disorders.
4 in platelet production can lead to inherited platelet disorders.
5 edicine and in high turnover/high activation platelet disorders.
6  a spectrum of congenital red blood cell and platelet disorders.
7 the management of thrombocytopenia and other platelet disorders.
8 oter-driven MuLV vectors for gene therapy of platelet disorders.
9 l applications toward human gene therapy for platelet disorders.
10 ombocytopenic disorders, including inherited platelet disorders.
11 ts of patients with constitutional (familial platelet disorder/acute myeloid leukemia) or acquired (c
12 matologic malignancies that include familial platelet disorder/acute myeloid leukemia, primary or sec
13 similar to that seen in patients with Quebec platelet disorder, affirming the role of ectopic urokina
14  a large pedigree with an autosomal dominant platelet disorder and a striking propensity in affected
15  a new and simple tool to identify inherited platelet disorders and myeloid neoplasms with abnormalit
16 ng the mutant loci in a variety of inherited platelet disorders, and these findings are beginning to
17                                Some familial platelet disorders are associated with predisposition to
18       The molecular causes of many inherited platelet disorders are being unraveled.
19 elet membrane is the cause of the congenital platelet disorder Bernard-Soulier syndrome (BSS).
20 nrelated families in the BRIDGE Bleeding and Platelet Disorders (BPD) collection who carry a TPM4 var
21  variants for rare bleeding, thrombotic, and platelet disorders (BTPDs) observed in 12 367 UKB partic
22 ssociated with rare bleeding, thrombotic, or platelet disorders (BTPDs).
23 thrombocytopenia (HIT) is an immune-mediated platelet disorder caused by antibodies that target compl
24  Glanzmann thrombasthenia (GT), an inherited platelet disorder caused by mutations in integrin alphaI
25 s with ITP seen at the New York Presbyterian Platelet Disorder Center in the past 10 years.
26  Glanzmann's thrombasthenia is a qualitative platelet disorder characterized by a deficiency in the p
27                        FPD/AML is a familial platelet disorder characterized by platelet defects, pre
28         To prevent and treat immune-mediated platelet disorders (e.g. neonatal allo-immune thrombocyt
29 nic sequestration and destruction in various platelet disorders, especially idiopathic thrombocytopen
30                  For patients with inherited platelet disorders, ex vivo-generated platelets offer th
31                                     Familial platelet disorder (FPD) is associated with germline RUNX
32 mpared with HPCs from patients with familial platelet disorder (FPD), or normal untransformed HPCs.
33                        One rare example of a platelet disorder, Glanzmann thrombasthenia (GT), is cha
34            In certain forms of the inherited platelet disorder, Glanzmann thrombasthenia (GT), mutant
35                                              Platelet disorders have been successfully modeled and ge
36                                   Hereditary platelet disorders (HPDs) are a group of blood disorders
37 1-3p22.1 has not been previously linked to a platelet disorder; identification of the GPS gene will l
38 th GT and describe how we manage this severe platelet disorder in our clinical practice.
39 ing actin dynamics have been associated with platelet disorders in humans and mice.
40 nts in inherited diseases, such as inherited platelet disorders (IPDs), remains a major clinical chal
41 harboring variants responsible for inherited platelet disorders (IPDs).
42     By implication, in patients experiencing platelet disorders, platelet (dys)function is almost com
43 appears to be an additional and (at least in platelet disorders) -possibly clinically relevant mechan
44                                       Quebec platelet disorder (QPD) is an autosomal dominant bleedin
45 malities in human patients with the familial platelet disorder resulting from AML1 haploinsufficiency
46  Variants causal of some autosomal recessive platelet disorders revealed phenotypic consequences in c
47  vaccination; and surveys distributed by the Platelet Disorder Support Association (PDSA) and the Uni
48 mbocytopenia (ITP), an autoantibody-mediated platelet disorder that currently lacks a reliable biomar
49  syndrome (GPS) is a predominantly recessive platelet disorder that is characterized by mild thromboc
50 stian (SBS) syndromes are autosomal dominant platelet disorders that share macrothrombocytopenia and
51 on factor RUNX1 are associated with familial platelet disorder, thrombocytopenia, and predisposition
52 report the linkage of the autosomal dominant platelet disorder to markers on chromosome 21q22.
53 es in pedigrees with unexplained bleeding or platelet disorders to data from 5422 controls.
54          It belongs to a group of hereditary platelet disorders typified by normal platelet numbers a
55                   The nature of an inherited platelet disorder was investigated in three siblings aff
56                       Patients with familial platelet disorder with a predisposition to myeloid malig
57 e protease neutrophil elastase, and familial platelet disorder with acute myelogenous leukemia (AML),
58 ay platelet syndrome (GPS), a rare recessive platelet disorder with alpha-granule abnormalities and m
59 ion domain, found in a patient with familial platelet disorder with AML, fails to stimulate the ELA2
60 riants cause the autosomal dominant familial platelet disorder with associated myeloid malignancy (FP
61 factor 1 (RUNX1) are causative of a familial platelet disorder with associated myeloid malignancy (FP
62 cription factor RUNX1 is mutated in familial platelet disorder with associated myeloid malignancy (FP
63   Monoallelic RUNX1 mutations cause familial platelet disorder with predisposition for acute myelogen
64                                     Familial platelet disorder with predisposition to acute myelogeno
65                                     Familial platelet disorder with predisposition to acute myeloid l
66 e well-described autosomal-dominant familial platelet disorder with predisposition to hematologic mal
67 a (AML) and in association with the familial platelet disorder with propensity to develop AML (FPD/AM